Creatine and glutamine are two of the most studied nutritional compounds in exercise and clinical nutrition. Their potential roles in wound and injury healing are mechanistically compelling — but the clinical evidence is highly domain-specific. Glutamine shows meaningful support for burn patients and post-GI surgical recovery; creatine’s most relevant evidence is for active muscle rehabilitation. For tendon, ligament, and bone fracture healing, neither compound has been adequately tested in humans.

When Your Body’s Demand Outstrips Supply

Severe injuries don’t just damage tissue — they dramatically alter the body’s biochemical landscape. After a major burn, serious surgery, or critical illness, skeletal muscle begins breaking itself down to supply the body’s suddenly increased demands for fuel, immune substrates, and nitrogen. Plasma levels of the amino acid glutamine — normally abundant — can fall by 40–60% within hours. Creatine stores in muscle are depleted by injury-related muscle breakdown and reduced dietary intake during recovery.

These are not trivial depletions. Glutamine is the primary fuel for the immune cells fighting infection in the wound bed, and it is needed to maintain the gut barrier that keeps intestinal bacteria from entering the bloodstream. Creatine supports the ATP availability that powers every cellular repair process. When both are in short supply at precisely the moment the body needs them most, the question of supplementation becomes clinically interesting — and the research is worth understanding in detail.

What These Compounds Are

Creatine: The Energy Currency Restorer

Creatine is a nitrogenous compound synthesised in the liver from three amino acids — arginine, glycine, and methionine — and stored predominantly as phosphocreatine in skeletal muscle. Its primary function is to regenerate ATP during high-demand periods via the creatine kinase reaction. Beyond energy metabolism, creatine activates the mTOR anabolic signalling cascade (stimulating muscle protein synthesis), promotes satellite cell proliferation (the muscle stem cells required for tissue repair), and may stabilise cell membranes against inflammatory stress.

Glutamine: The Conditionally Essential Amino Acid

Glutamine is the most abundant free amino acid in human plasma and muscle. Under normal conditions it is synthesised in adequate quantities, but during severe injury, surgery, or burns, tissue demand far outstrips endogenous production — making glutamine “conditionally essential.”

Why Glutamine Becomes Critical During Injury

The Evidence Picture at a Glance

The evidence for these two compounds is notably asymmetric — strong for glutamine in specific acute care settings, more limited and domain-specific for creatine. The table below reflects the clinical research reviewed for this article.

Glutamine in Burns: The Strongest Clinical Signal

The most consistently supported clinical application for either compound is enteral glutamine in adult burn patients. A meta-analysis pooling approximately 22 randomized controlled trials (total n≈2,170) found that patients receiving enteral glutamine at 0.3–0.5 g/kg/day experienced wound healing approximately 5.8 days earlier than controls and had a wound infection relative risk of approximately 0.38 — a substantial reduction.

This isn’t a single lucky trial. The finding has been replicated across multiple independent research groups, in different countries, using varied supplementation protocols. The mechanistic pathway is coherent: glutamine restores the fuel supply for neutrophils and macrophages fighting wound infection while simultaneously maintaining gut barrier integrity and glutathione-dependent antioxidant defence.

Creatine and Muscle Rehabilitation: Promising but Specific

For creatine, the most clinically interesting finding comes from a controlled disuse atrophy study. In one RCT (Hespel et al., 2001), healthy young adults had a limb immobilised for two weeks, then underwent ten weeks of active rehabilitation with either creatine or placebo. During immobilisation, creatine provided no benefit. But during the active rehabilitation phase — when subjects were performing progressive resistance exercise — the creatine group demonstrated significantly faster recovery of cross-sectional area and maximal power output compared to placebo.

For exercise-induced muscle damage, two meta-analyses support moderate evidence that creatine supplementation reduces serum creatine kinase (CK) at 48–96 hours post-exercise — a marker of muscle membrane disruption. Whether this represents genuine tissue protection or simply reduced enzyme leakage without functional benefit remains unclear, as perceived soreness and strength recovery outcomes are not consistently improved in the same trials.

Who Is This Most Relevant For?

Burn patients (non-critically ill): Glutamine supplementation has the best evidence here. Enteral administration at 0.3–0.5 g/kg/day during the acute care phase appears to reduce healing time and infection risk. Clinical teams should follow site-specific critical care protocols.

Post-GI surgery patients: Glutamine’s gut barrier and immune-support properties are most relevant where intestinal mucosa is directly disrupted. Evidence supports consideration of peri-operative enteral supplementation.

Athletes and active individuals recovering from muscle injury: Creatine may support the active rehabilitation phase. The evidence is modest and requires replication, but the mechanism is sound and safety is well-established at standard doses.

Critically ill patients with multiorgan failure: High-dose IV glutamine should not be used based on the RE-ENERGIZE signal. This is not a context for self-supplementation — only critical care teams can assess the risk-benefit here.

People recovering from tendon injuries, ligament repairs, or bone fractures: There is currently insufficient clinical trial evidence to support a recommendation for either compound in these specific contexts. Mechanistic plausibility exists, but plausibility is not the same as clinical evidence.

What the Research Doesn’t Yet Tell Us

The evidence gaps here are substantial and clinically important. Neither compound has been tested in a clinical trial specifically for tendon or ligament healing in adults. The one creatine tendon trial enrolled adolescent competitive swimmers with overuse injuries — a very different population from an adult with an ACL rupture or Achilles tear.

No RCTs have evaluated either creatine or glutamine for bone fracture healing specifically. Creatine’s positive post-surgical orthopaedic evidence is essentially absent: both the ACL reconstruction trial (Tyler et al., 2004) and the total knee arthroplasty trial found no functional benefit from creatine. And critically, the creatine-glutamine combination — despite being mechanistically complementary — has never been tested together in a clinical trial for any injury indication.

Bottom Line